Clinical variability and molecular heterogeneity in prostate cancer

by Jonathan Shoag, Christopher E Barbieri
Published 2016-01-01

Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma

by Johannes C. van der Mijn, Leiping Fu, Francesca Khani, Tuo Zhang, Ana M. Molina, Christopher E. Barbieri, Qiuying Chen, Steven S. Gross, Lorraine J. Gudas, David M. Nanus
Published 2020-02-01

Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations

by Davide Prandi, Sylvan C. Baca, Alessandro Romanel, Christopher E. Barbieri, Juan-Miguel Mosquera, Jacqueline Fontugne, Himisha Beltran, Andrea Sboner, Levi A. Garraway, Mark A. Rubin, Francesca Demichelis
Published 2017-05-01

Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer

by Spyridon P. Basourakos, Michael Tzeng, Patrick J. Lewicki, Krishnan Patel, Bashir Al Hussein Al Awamlh, Siv Venkat, Jonathan E. Shoag, Jonathan E. Shoag, Michael A. Gorin, Michael A. Gorin, Christopher E. Barbieri, Jim C. Hu
Published 2021-05-01

Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes

by Salma Ben-Salem, Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irene Wang, Varadha Balaji Venkadakrishnan, Dhirodatta Senapati, Sangeeta Kumari, Deli Liu, Andrea Sboner, Christopher E. Barbieri, Felix Feng, Jean-Noel Billaud, Elai Davicioni, Song Liu, Hannelore V. Heemers
Published 2020-12-01

SPOP mutation leads to genomic instability in prostate cancer

by Gunther Boysen, Christopher E Barbieri, Davide Prandi, Mirjam Blattner, Sung-Suk Chae, Arun Dahija, Srilakshmi Nataraj, Dennis Huang, Clarisse Marotz, Limei Xu, Julie Huang, Paola Lecca, Sagar Chhangawala, Deli Liu, Pengbo Zhou, Andrea Sboner, Johann S de Bono, Francesca Demichelis, Yariv Houvras, Mark A Rubin
Published 2015-09-01

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

by Hui Wang, Christopher E. Barbieri, Jintang He, Yuqian Gao, Tujin Shi, Chaochao Wu, Athena A. Schepmoes, Thomas L. Fillmore, Sung-Suk Chae, Dennis Huang, Juan Miguel Mosquera, Wei-Jun Qian, Richard D. Smith, Sudhir Srivastava, Jacob Kagan, David G. Camp, Karin D. Rodland, Mark A. Rubin, Tao Liu
Published 2017-08-01

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

by Deli Liu, Jonathan E. Shoag, Daniel Poliak, Ramy S. Goueli, Vaishali Ravikumar, David Redmond, Aram Vosoughi, Jacqueline Fontugne, Heng Pan, Daniel Lee, Domonique Thomas, Keyan Salari, Zongwei Wang, Alessandro Romanel, Alexis Te, Richard Lee, Bilal Chughtai, Aria F. Olumi, Juan Miguel Mosquera, Francesca Demichelis, Olivier Elemento, Mark A. Rubin, Andrea Sboner, Christopher E. Barbieri
Published 2020-04-01

SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts

by Mirjam Blattner, Daniel J. Lee, Catherine O'Reilly, Kyung Park, Theresa Y. MacDonald, Francesca Khani, Kevin R. Turner, Ya-Lin Chiu, Peter J. Wild, Igor Dolgalev, Adriana Heguy, Andrea Sboner, Sinan Ramazangolu, Haley Hieronymus, Charles Sawyers, Ashutosh K. Tewari, Holger Moch, Ghil Suk Yoon, Yong Chul Known, Ove Andrén, Katja Fall, Francecsa Demichelis, Juan Miguel Mosquera, Brian D. Robinson, Christopher E. Barbieri, Mark A. Rubin
Published 2014-01-01